Management of abnormal uterine bleeding in adolescents

Journal of Pediatric and Adolescent Gynecology

Volumn 23, Issue SUPPL. 6, 2010, Pages

  Wilkinson, Jeffrey P ^a   Kadir, Rezan A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Abnormal Uterine Bleeding; Adolescents; Bleeding Disorders; Menorrhagia

Indexed keywords

AMINOCAPROIC ACID; ANTIGESTAGEN; CONJUGATED ESTROGEN; DANAZOL; DESMOPRESSIN; ERGOMETRINE; GESTAGEN; IBUPROFEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; MISOPROSTOL; NAPROXEN; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; HORMONE; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ABNORMAL UTERINE BLEEDING; ADOLESCENT DISEASE; ARTICLE; BLOATING; BREAST TENDERNESS; CURETTAGE; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILY HISTORY; FATIGUE; FEMALE FERTILITY; FLUID RETENTION; HEADACHE; HUMAN; HYSTERECTOMY; MEDICAL HISTORY; MENSTRUAL CYCLE; MOOD CHANGE; MORBIDITY; NAUSEA; NAUSEA AND VOMITING; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SKIN DISEASE; THROMBOEMBOLISM; TRANSDERMAL PATCH; UTERUS BLEEDING; VAGINA RING; VENOUS THROMBOEMBOLISM; WEIGHT GAIN; ADOLESCENT; ADULT; BALLOON DILATATION; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; CHILD; FEMALE; MENORRHAGIA; THROMBOCYTE TRANSFUSION; UTERINE ARTERY EMBOLIZATION;

ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; BALLOON DILATION; BLOOD COAGULATION DISORDERS; CHILD; FACTOR VIIA; FEMALE; HEMORRHAGIC DISORDERS; HEMOSTATICS; HORMONES; HUMANS; MENORRHAGIA; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; UTERINE ARTERY EMBOLIZATION; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 79952278453     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.08.007     Document Type: Article

References (55)

1. Barr F., Brabin L., Agbaje S., et al. Reducing iron deficiency anaemia due to heavy menstrual blood loss in Nigerian rural adolescents. Public Health Nutr 1998, 1:249.
2. Chan S., Yiu K., Yuen P., et al. Menstrual problems and health-seeking behaviour in Hong Kong Chinese girls. Hong Kong Med J 2009, 15:18.
3. Friberg B., Ornö A., Lindgren A., et al. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol 2006, 85:200.
4. Lee L.K., Chen P., Lee K.K., et al. Menstruation among adolescent girls in Malaysia: a cross-sectional school survey. Singapore Med J 2006, 4:869.
5. Cakir M., Mungan I., Karakas T., et al. Menstrual pattern and common menstrual disorders among university students in Turkey. Pediatr Int 2007, 49:938.
6. Woolcock J.G., Critchley H.O., Munro M.G., et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008, 90:2269.
7. Fraser I.S., Critchley H.O., Munro M.G., et al. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Hum Reprod 2007, 22:635.
8. Lobo R. Abnormal Uterine Bleeding in Comprehensive Gynecology 2007, Mosby, Philadelphia, Chapter 3. 5th ed.
9. Read G.F., Wilson D.W., Hughes I.A., et al. The use of salivary progesterone assays in the assessment of ovarian function in postmenarchal girls. J Endocrinol 1984, 102:265.
10. Vikho R., Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984, 20:231.
11. Mikhail S., Varadarajan R., Kouides P. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre. Haemophilia 2007, 13:627.
12. Jayasinghe Y., Moore P., Donath S., et al. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol 2005, 45:439.
13. Bevan J.A., Maloney K.W., Hillery C.A., et al. Bleeding disorders: A common cause of menorrhagia in adolescents. J Pediatr 2001, 138:856.
14. Oral E., Caĝdaş A., Gezer A., et al. Hematologic abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 2002, 266:72.
15. Smith Y.R., Quint E.H., Hertzberg R.B. Menorrhagia in adolescents requiring hospitalization. J Pediatr Adolesc Gynecol 1998, 11:13.
16. Claessens E., Cowell C. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 1981, 28:369.
17. Philipp C.S., Faiz A., Dowling N., et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005, 105:61.
18. Dilley A., Drews C., Lally C., et al. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med 2002, 11:39.
19. Chi C., Shiltagh N., Kingman C., et al. Identification and management of women with inherited bleeding disorders: a survey of obstetricians and gynaecologists in the United Kingdom. Haemophilia 2006, 12:405.
20. Gray S.H., Emans S.J. Abnormal vaginal bleeding in adolescents. Pediatr Rev 2007, 28:175.
21. Kadir R.A., Economides D.L., Sabin C.A., et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998, 351:485.
22. Rodeghiero F., Castaman G., Tosetto A., et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005, 3:2619.
23. Rodeghiero F, Tosetto A, Abshire T, et al, on behalf of the ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC Bleeding Assessment Tool: A Standardized Questionnaire and a Proposal for a New Bleeding Score for Inherited Bleeding Disorders. In press JTH.
24. Anastasakis E., Kingman C., Griffionen A., et al. Menstrual problems in university students: an electronic mail survey. Vivo 2008, 22:617.
25. Warner P.E., Critchley H.O., Lumsden M.A., et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004, 190:1216.
26. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign 2006, ACOG, DC. American Congress of Obstetricians and Gynecologists, Washington.
27. Higham J.M., O'Brien P.M., Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 2005, 97:734.
28. Reid P.C., Coker A., Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG 2000, 107:320.
29. Barr F., Brabin L., Agbaje O. A pictorial chart for managing common menstrual disorders in Nigerian adolescents. Int J Gynaecol Obstet 1999, 66:51.
30. Tanweer K., Patil K., Panchal A. A case of a giant fibroid in an adolescent girl. Calicut Med J 2009, 7:e6.
31. Amesse L., Taneja A., Broxson E., et al. Protruding giant cervical polyp in a young adolescent with a previous rhabdomyosarcoma. J Pediatr Adolesc Gynecol 2002, 15:271.
32. De Raucourt E., Ternisien C. [Appropriate laboratory investigation in women with menorrhagia]. J Gynecol Obstet Biol Reprod 2008, 8(37 Suppl):317.
33. Beller F.K., Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv 1985, 40:425-436.
34. James A.H., Kouides P.A., Abdul-Kadir R., et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009, 201:12.e1.
35. Sidonio R.F., Smith K.J., Ragni M.V. Cost-Utility Analysis of von Willebrand Disease Screening in Adolescents with Menorrhagia. J Pediatr 2010, in press.
36. Falcone T., Desjardins C., Bourque J., et al. Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994, 39:761.
37. Chi C., Pollard D., Tuddenham E.G., et al. Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol 2010, 23:215.
38. Lethaby A., Farquhar C., Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000, CD000249.
39. Sundström A., Seaman H., Kieler H., et al. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. BJOG 2009, 116:91.
40. Lindoff C., Rybo G., Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 1993, 70:238.
41. Mohri H. High dose of tranexamic acid for the treatment of severe menorrhagia in patients with von Willebrand Disease. J Thromb Thrombolysis 2002, 14:255.
42. Kouides P.A., Byams V.R., Phillipp C.S., et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009, 145:212.
43. Edlund M., Blomback M., Fried G. Desmopressin in the treatment of menorrhagia and no common coagulation factor deficiency but with prolonged bleeding time. Blood Coagul Fibrinolysis 2002, 13:225.
44. Lethaby A., Augood C., Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 1998, CD000400.
45. FFPRHC, Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guideline (October 2004). Contraceptive choices for young people. J Fam Plan Reprod Health Care 2004; 30:237-51.
46. Archer D.F. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 2006, 74:359.
47. Kingman C.E., Kadir R.A., Lee C.A., et al. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 2004, 111:1425.
48. Chi C., Haq Y., Kadir R. Levonorgestrel-releasing intrauterine system for the management of menorrhagia in women with inherited bleeding disorders: Long term follow-up. Contraception 2010, in press.
49. Intrauterine device and adolescents. Obstet Gynecol 2007, 110:1493. American College of Obstetricians and Gynecologists: ACOG Committee Opinion No. 392, December 2007.
50. Paterson H., Ashton J., Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 2009, 79:433.
51. National Institute for Health and Clinical Excellence. Heavy menstrual bleeding. Developed by the National Collaborating Centre for Women's and Children's Health; 2007. Report No: NICE clinical guideline 44 http://www.nice.org.uk/Guidance/CG/Published.
52. Fleming N., Francoeur D., Gascon S., et al. Management of acute adolescent menorrhagia. J Pediatr Adolesc Gynecol 2001, 14:141.
53. DeVore G., Owens O., Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding-a double-blind randomized control study. Obstet Gynecol 1982, 59:285.
54. Rouhani G., Menon S., Burgis J., et al. An unusual method to manage a rare blood dyscrasia. J Pediatr Adolesc Gynecol 2003, 20:S123.
55. Bowkley C., Dubel G., Haas R., et al. Uterine artery embolization for control of life-threatening haemorrhage at menarche: brief report. J Vasc Interv Radiol 2007, 18:127.